
|Articles|September 1, 2004
Added evidence points to importance of bone marrow-derived progenitor in CNV
Fort Lauderdale, FL-Studies in a preclinical model of experimentally induced choroidal neovascularization (CNV) indicate that circulating bone marrow-derived cells contribute significantly to the vascular and inflammatory components of CNV. That finding has potential implications for understanding of the pathophysiology of CNV associated with age-related macular degeneration (AMD) as well as for suggesting new therapeutic targets, according to the researchers from the Bascom Palmer Eye Institute, University of Miami.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Looking back at the 2025 EnVision Summit
4
Last year in glaucoma at EnVision Summit 2025
5




























